An NIH Director's Wednesday Afternoon Lecture Series Event
"Developing Treatment for Hereditary Neuromuscular Disease"
Speaker: Dr. Kenneth H. Fischbeck, MD
Wednesday, November 2, 2011
Clinical Center, Building 10
National Institutes of Health
Kenneth Fischbeck, will present the 14th annual Astute Clinician Lecture as part of the Wednesday Afternoon Lecture Series on November 2, 2011.
Dr. Kenneth Fischbeck, a NIH Distinguished Investigator and Chief, Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, will present the Annual Astute Clinician Lecture on November 2, 2011. His lecture, "Developing Treatment for Hereditary Neuromuscular Disease," can be viewed live via videocast.
Sign Language Interpreters will be provided. Individuals with disabilities who need accommodations to participate in this lecture should call 301-594-6747 or contact the Federal Relay Service at 1-800-877-8339. Requests should be made at least five days in advance of the event.
For information call Sarah Herrmann at 301-594-6747 or email@example.com.
Visit the Wednesday Afternoon Lecture Series Web site at http://wals.od.nih.gov.
Download the Flyer (785 KB)
The Astute Clinician Lecture Series
The Astute Clinician Lecture was established through a gift from the late Dr. Robert W. Miller and his wife, Haruko. It honors a US scientist who has observed an unusual clinical occurrence, and by investigating it, has opened an important new avenue of research.
Continuing Medical Education (CME) activities offered by NIH are jointly sponsored in partnership with The Johns Hopkins University School of Medicine Office of CME.
The WALS is intended for advanced students and practitioners in biomedical fields, healthcare professionals, and doctoral-level scientists who seek to update and broaden their understanding of contemporary biomedical research and the environment in which it is conducted.
Activity Description: The Wednesday Afternoon Lecture Series provides a mechanism to stay abreast of state-of-the-art biomedical and health research.
Intended Audience: All physicians, allied health professionals and non-clinical scientists, as well as the general public, are invited to attend the Wednesday Afternoon Lecture Series.
Objectives: After attending the activity, participants will be able to: (1) define options, alternatives, and new practices that will guide the conduct of research; (2) evaluate practical information presented about laboratory, clinical, and population-based research principles based on state-of-the-art scientific discovery and achievements; and (3) analyze information and opportunities to increase and improve collaboration among investigators and move scientific frontiers forward.
Accreditation Statement: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The Johns Hopkins University School of Medicine and the National Institutes of Health. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement: The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 39 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Policy on Speaker and Provider Disclosure: It is the policy of The Johns Hopkins University School of Medicine that the speaker and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). The Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the activity handout materials.
Past Astute Clinician Lectures
"Genes versus Fast Food: Eat, Drink and Be Wary"
November 17, 2010 - Dr. Helen Hobbs
"Fevers, Genes, and Histories: Adventures in the Genomics of Inflammation"
November 18, 2009 - Dr. Daniel Kastner
"Marfan Syndrome and Releated Disorders: from Molecules to Medicines"
January 14, 2009 - Harry Dietz, MD
"From the Rivers of Babylon to the Coronary Blood Stream"
November 7, 2007 - Dr. Barry S. Coller, MD
"Listening to Patients: Lessons Learned in the Development of Cancer Immunotherapy"
November 1, 2006 - Dr. Steven A. Rosenberg, M.D.
"Inflammation, CRP and Cardiovascular Risk: Is It Time to Change the Framingham Risk Score?"
November 2, 2005 - Dr. Paul M. Ridker, M.D.
"Insulin Resistance and Metabolic Syndromes: Different Names, Different Concepts, Different Goals"
November 3, 2004 - Dr. Gerald M. Reaven, M.D.
"Cochlear Implants, Past, Present, and Future,"
November 5, 2003 - Richard T. Myamoto, M.D.
"AIDS: A Window on Infectious Diseases,"
November 06, 2002 - Henry Masur, M.D.,
"STI571: A Tyrosine Kinase Inhibitor for the Treatment of Chronic Myelogenous Leukemia (CML) Validating the Promise of Molecularly Targeted Therapy,"
November 07, 2001 - Brian Druker, M.D.
"The Patients Who Taught Me and Led to My Discoveries in Congenital Adrenal Hyperplasia,"
December 13, 2000 - Maria I. New, M.D.
"The Elucidation of Lyme Arthritis,"
November 3, 1999 - Allen C. Steere, M.D.
"The Link Between Teratogenesis and Carcinogenesis: Lessons from the Wilms Tumor Model.,"
October 15, 1998 - Dr. J. Bruce Beckwith